Skip to main content
Clinical Trials/CTRI/2024/03/064550
CTRI/2024/03/064550
Not yet recruiting
Phase 2

A clinical study of Haritakyadi Churna with special reference to ??? ??? ? ????? ???? in management of Amavata. - NI

Institute of Medical Science Faculty of Ayurveda0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
Sponsor
Institute of Medical Science Faculty of Ayurveda
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Institute of Medical Science Faculty of Ayurveda

Eligibility Criteria

Inclusion Criteria

  • Clinical feature of disease according to modern and Ayurveda.
  • Fulfilling the criteria for diagnosis of rheumatoid arthritis approved by Disease activity score 28 and ACR EULAR2010\.
  • Chronicity of disease not more than 3 years.
  • Patients willing to participate in the above trial and given informed consent.

Exclusion Criteria

  • Patients suffering from any other acute disease/any infectious disease /chronic disease.
  • Patients having severe deformities.
  • Severe ankylosed joints and Ankylosing Spondylitis.
  • Rheumatic Arthritis, Septic Arthritis, Osteoarthritis and Gouty Arthritis.
  • Rheumatoid Arthritis associated with other systemic disorder.

Outcomes

Primary Outcomes

Not specified

Similar Trials